01235 832023
Source The Guardian: The barrier between mind and body appears to be crumbling. Clinical practice and public perception need to catch up. Unlikely as it may seem, #inflammation has become a hashtag. It seems to be everywhere suddenly, up to all sorts of tricks. Rather than simply being on our side, fighting infections and healing wounds,… Read more »
Source Multiple Sclerosis News Today: Regeneration in the brain is reduced in people with primary progressive multiple sclerosis (PPMS), but enhanced during disease activity in those with relapsing-remitting MS (RRMS), a study reports. The results also show that regeneration is unaffected by treatment with disease-modifying therapies (DMTs), as shown by the levels of a regeneration marker in the brain called growth-associated protein… Read more »
Source Pipeline Review: Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) Begins Enrollment. The Immune Tolerance Network (ITN) opened the BEAT-MS clinical trial for enrollment. BEAT-MS or “Best Available Therapy vs. Autologous Hematopoietic Stem Cell Transplant (AHSCT) for MS” will investigate high dose immunosuppression followed by AHSCT –… Read more »
Source MS Trust: NICE has published its final decision recommending that Plegridy can be prescribed by the NHS for relapsing-remitting MS. In May 2018, NICE carried out a review of several of the MS drugs and decided that Avonex, Extavia, Rebif, Copaxone and Brabio should continue to be available on the NHS in England. At the time, NICE was unable to make a recommendation on… Read more »
Source MS Society: The MS Society went to 10 Downing Street yesterday with their ambassador Janis Winehouse and campaigner Ashley Arundale to deliver a message to the PM: Unfair PIP assessments must change. “More than 21,000 of us have signed an open letter demanding the UK Government makes changes to Personal Independence Payment (PIP). The open… Read more »
Source Winter Sports Travel: Making Travel Accessible. Winter sports are becoming more accessible than ever before. But finding the right place or activity when you’re living with a challenging condition can be tough. Try this tool to find sports and resorts in Europe that are tailored to your needs. Click here.
Source The Lancet: Neurodegeneration is the pathological substrate that causes major disability in secondary progressive multiple sclerosis. A synthesis of preclinical and clinical research identified three neuroprotective drugs acting on different axonal pathobiologies. We aimed to test the efficacy of these drugs in an efficient manner with respect to time, cost, and patient resource. Methods We… Read more »
Source MS Society: This week the European Medicines Agency (EMA) granted a license for siponimod (brand name Mayzent) to treat adults with secondary progressive MS with active disease. That makes siponimod the first and only oral treatment in Europe specifically for patients with secondary progressive MS with active disease. What was the evidence? The drug approval… Read more »
We would be grateful for donations of any unwanted Christmas presents that we can use for raffle prizes. Please bring them to the Centre and we can find them a loving home whilst raising much-needed funds for the Centre!
Message received from Beryl’s daughter….. Thank you so much for your reply; and kind words. It’s still hard to believe she’s gone and we miss her. The funeral is this Friday 17th January at 11amGarden House, Milton Hill, Steventon, Oxon OX13 6AF You would be very welcome and please could you let her other friends… Read more »